PrEP HIV - JD DME
PrEP HIV
Effective September 30, 2024, CMS will cover pre-exposure prophylaxis (PrEP) using antiretroviral drugs approved by the U.S. Food and Drug Administration (FDA) to prevent HIV in individuals at increased risk of HIV acquisition.
2024
Last Updated Apr 07 , 2025